Schedule 13G ownership disclosure

BELLEROPHON THERAPEUTICS INC

Common Stock, par value $0.01 per share · CUSIP: 078771300

Event date: 2024-01-16

Filing-level shares
642,844.00
Percent of class
5.3%
  • Nelson Michael Aaron

    Shares: 642,844.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002009141-24-000001
Form type
SCHEDULE 13G
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
Jan 26, 2024
Reporting period
Jan 16, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub